{"disease":{"id":"treatment-of-acute-bacterial-sinusitis-abs-caused-by-haemophilus-influenzae-haemophilus-parainfluenzae-or-moraxella-catarrhalis-in-patients-who-have-a-penicillin-tolerance-test-result-of-20-mcg-ml","name":"treatment of acute bacterial sinusitis abs caused by haemophilus influenzae haemophilus parainfluenzae or moraxella catarrhalis in patients who have a penicillin tolerance test result of 20 mcg ml"},"drugs":{"marketed":[{"drug_id":"atm-avi","indication_name":"Treatment of acute bacterial sinusitis (ABS) caused by Haemophilus influenzae, Haemophilus parainfluenzae, or Moraxella catarrhalis in patients who have a penicillin tolerance test result of >= 20 mcg/mL.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Atm-Avi","generic_name":"atm-avi","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"unknown","drug_class":"antibiotic","quality_score":37,"revenue":null,"mechanism":"ATM-AVI's mechanism of action is not specified on Wikipedia."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}